Japan's GDP growth is not as important as higher company profit margins, says John Vail at Nikko AM Americas.
Vanguard International's James Norris talks about the company's mission to educate Chinese investors after gaining its wholly foreign-owned entity license.
Donald Trump's administration picks include both establishment and insurgent politicians, says Thad Kousser at UC San Diego.
GDP and earnings growth in the U.S. might be picking up, but there are still headwinds ahead, says Chad Morganlander at Stifel.
CNBC's Akiko Fujita reports on how Google's Next Billion Users project is empowering communities by giving them exposure to the internet.
Dickie Wong of Kingston Securities talks about the recent performance of HSBC shares.
China still wants to compete in exports and is likely to favor a lower yuan, says Arthur Kwong at BNP Paribas Investment Partners.
India is leapfrogging the traditional retail landscape for e-commerce, says Kunal Bahl, CEO of Snapdeal.
Stratfor's Rodger Baker weighs in South Korea's political woes.
A contraction in net export growth and a weaker labor market account for Australia's poor Q3 GDP, says Gareth Aird at Commonwealth Bank.
Jack McIntyre at Brandywine Global IM says that Trump doesn't want to lead with protectionism or a strong dollar, and this could bring relief to EMs.
Asian markets opened in the green on Thursday, on the back of yet another record high from the Dow.
The ECB is close to the end of its projected QE end date, says William Adams at PNC.
Trump looks set to continue his antagonistic tone when it comes to China, says James Battista at the University at Buffalo.
The markets are set to decline mid-2017 as the cycle ends against rising rates, says Vadim Zlotnikov at AB.
Harsh Mariwala, chairman of Marico, talks about the potential impact of India's new goods and services tax and the country's manufacturing push.
Simon Flowers at Wood Mackenzie discusses how India will deal with potentially higher oil prices.
Manufacturing has shifted to other low-cost hubs while global demand remains limp, says Francis Lun of GEO Securities.
CNBC's Martin Soong reports on the growth potential of the pharmaceutical industry in India, the largest generic drug producer in the world.
Unless there's another big rally in the dollar, the worst is behind for emerging markets, says Frederic Neumann, MD at HSBC.